70 results
424B5
ATRA
Atara Biotherapeutics Inc
9 Jan 24
Prospectus supplement for primary offering
4:28pm
or experience significant delays in doing so, our business may be materially harmed;
we will require substantial additional financing to achieve our goals
424B3
ATRA
Atara Biotherapeutics Inc
17 Nov 23
Prospectus supplement
4:31pm
to achieve our goals, and a failure to obtain this necessary capital when needed could force us to delay, limit, reduce or terminate our product
S-8
EX-4.3
wa0bq00vhfaexk
22 Jul 22
Registration of securities for employees
4:06pm
S-8
EX-4.3
h2wxk99gxemyhfl w1p1
29 Sep 21
Registration of securities for employees
4:26pm